Topic 397 - microfluidic transfection platform for rapid manufacturing of mrna car lymphocyte products.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91020C00028
- Awardee
-
Cellfe, Inc. UEI M34JNT47EKK3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $358,930
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Solicitation · PHS20201 · Posted Jun 21, 2019
- Contract value 100% obligated
- $358,930.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Carlos, CA 94070, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
This SBIR Phase I contract was awarded by the National Institutes of Health's National Cancer Institute to Cellfe Inc. for $358,930. The contract is for the period of September 8, 2020 through June 7, 2021 and involves research and development of a microfluidic transfection platform for rapid manufacturing of mRNA CAR lymphocyte products. The solicitation sought proposals to conduct R&D in support of NIH and CDC agency missions, including alternatives to cell culture materials and cancer immunotherapy manufacturing. This total small business set-aside contract was awarded under the NIH/CDC SBIR program, which provides up to $250,000 for Phase I and up to $1,000,000 for Phase II contracts to small businesses for innovative research with potential for commercialization and public benefit. Work will be performed by Cellfe Inc. in San Carlos, California.
Quick answers
Who was awarded contract 75N91020C00028?
75N91020C00028 was awarded to Cellfe, Inc. by National Cancer Institute (National Institutes of Health) on September 8, 2020.
How much is contract 75N91020C00028 worth?
The government has obligated $358,930 on 75N91020C00028.
Was contract 75N91020C00028 competed?
The extent of competition for 75N91020C00028 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award